Document Detail

The mesothelium under the siege of dialysis solutions: old glucose, new glucose, and glucose-free osmotic agents.
MedLine Citation:
PMID:  19886309     Owner:  NLM     Status:  MEDLINE    
Use of one bag of glucose peritoneal dialysis fluid (PDF) results in the development of a dose-related senescent mesothelial cell phenotype not linked to acidic pH or the presence of lactate buffer. This complication derives mostly from oxidative stress induced both by glucose itself and by glucose degradation products (GDPs). New glucose formulations are offered in dual- or three-chambered bags, keeping the glucose at a low pH. The result is a reduced presence but not complete elimination of GDPs. These formulations have the potential to slow injury to the peritoneal membrane. Icodextrin and amino-acid PDFs, used for one exchange daily, have advantages and drawbacks alike. Icodextrin offers excellent ultrafiltration, but on the other hand, mesothelial cells incubated with this osmotic agent show reduced viability and proliferation and DNA damage. These unwanted effects appear to result from a substantial degree of oxidative stress. An amino-acid-based PDF offers a positive nutritional effect; however its ultrafiltration capability is not higher than an equimolar 1.5% glucose solution. Amino-acid solution appears to be more biocompatible than glucose-based fluid. So far glucose PDF offered in a single-compartment bag is not a biocompatible solution for long-term peritoneal dialysis. Icodextrin does not appear to be more biocompatible than glucose. Amino-acid-based solution is less harmful to the mesothelium, but its usefulness is still limited.
Lazaro Gotloib
Related Documents :
25378659 - Genetic loci associated with circulating levels of very long-chain saturated fatty acids.
11539119 - Radiolysis of aqueous solutions of acetic acid in the presence of na-montmorillonite.
25461899 - An adverse outcome pathway framework for neural tube and axial defects mediated by modu...
25329159 - Supplementation with n-3 long-chain polyunsaturated fatty acids or olive oil in men and...
25117649 - Effects of 20 standard amino acids on the growth, total fatty acids production, and γ-...
11484939 - Network formation of low molecular weight hyaluronic acid derivatives.
18650269 - Goat milk free fatty acid characterization during conventional and ohmic heating pasteu...
15237949 - Formation and evolution of monoepoxy fatty acids in thermoxidized olive and sunflower o...
21406729 - Inhibition of srebp1 sensitizes cells to death ligands.
Publication Detail:
Type:  Journal Article; Review    
Journal Detail:
Title:  Advances in peritoneal dialysis. Conference on Peritoneal Dialysis     Volume:  25     ISSN:  1197-8554     ISO Abbreviation:  Adv Perit Dial     Publication Date:  2009  
Date Detail:
Created Date:  2009-11-05     Completed Date:  2009-12-15     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  9104803     Medline TA:  Adv Perit Dial     Country:  Canada    
Other Details:
Languages:  eng     Pagination:  6-10     Citation Subset:  IM    
Laboratory of Experimental Nephrology, Ha'Emek Medical Center, Afula, Israel.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Amino Acids / analysis,  pharmacology
Biocompatible Materials / pharmacology
Epithelium / blood supply
Glucans / pharmacology
Glucose / analysis*,  pharmacology
Hemodialysis Solutions / chemistry,  pharmacology*
Oxidative Stress / drug effects
Peritoneal Dialysis*
Peritoneum / cytology,  drug effects*
Reg. No./Substance:
0/Amino Acids; 0/Biocompatible Materials; 0/Glucans; 0/Hemodialysis Solutions; 0/icodextrin; 50-99-7/Glucose

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Use of peritoneal dialysis and mesothelium in non primary renal conditions.
Next Document:  Urea transport across peritoneal membrane in vitro: influence of protamine sulfate, glyoxal, and met...